Neurology experts reviewed the latest evidence to offer new recommendations for management of painful neuropathy in diabetes patients.
Patients prescribed benzodiazepines and opioids by different providers 20% more likely to overdose, adding to already heightened risk.
Study looks at trends before and after 2016 guide for prescribers was released.
The cannabis-derived substance provides fewer side effects, with less potential for abuse.
The findings are a promising step for a disease with limited treatment options.